These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25807553)

  • 1. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia.
    Duber HC; Dansereau E; Masters SH; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masiye F; Njuguna P; Odeny T; Okiro E; Roberts DA; Gakidou E
    PLoS One; 2015; 10(3):e0120350. PubMed ID: 25807553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia.
    Di Giorgio L; Moses MW; Fullman N; Wollum A; Conner RO; Achan J; Achoki T; Bannon KA; Burstein R; Dansereau E; DeCenso B; Delwiche K; Duber HC; Gakidou E; Gasasira A; Haakenstad A; Hanlon M; Ikilezi G; Kisia C; Levine AJ; Maboshe M; Masiye F; Masters SH; Mphuka C; Njuguna P; Odeny TA; Okiro EA; Roberts DA; Murray CJ; Flaxman AD
    BMC Med; 2016 Jul; 14(1):108. PubMed ID: 27439621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.
    Chi BH; Mwango A; Giganti M; Mulenga LB; Tambatamba-Chapula B; Reid SE; Bolton-Moore C; Chintu N; Mulenga PL; Stringer EM; Sheneberger R; Mwaba P; Stringer JS
    J Acquir Immune Defic Syndr; 2010 May; 54(1):63-70. PubMed ID: 20009765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.
    Antinori A; Trotta MP; Nasta P; Bini T; Bonora S; Castagna A; Zaccarelli M; Quirino T; Landonio S; Merli S; Tozzi V; Di Perri G; Andreoni M; Perno CF; Carosi G
    Antivir Ther; 2006; 11(2):233-43. PubMed ID: 16640104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho.
    Jouquet G; Bygrave H; Kranzer K; Ford N; Gadot L; Lee J; Hilderbrand K; Goemaere E; Vlahakis N; Trivino L; Makakole L; Cleary S
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e68-74. PubMed ID: 21765366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa.
    Skhosana L; Steegen K; Bronze M; Lukhwareni A; Letsoalo E; Papathanasopoulos MA; Carmona SC; Stevens WS
    PLoS One; 2015; 10(2):e0118145. PubMed ID: 25659108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
    Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
    PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda.
    Dansereau E; Gakidou E; Ng M; Achan J; Burstein R; DeCenso B; Gasasira A; Ikilezi G; Kisia C; Masters SH; Njuguna P; Odeny TA; Okiro EA; Roberts DA; Duber HC
    PLoS One; 2015; 10(8):e0135653. PubMed ID: 26275151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    Brennan AT; Davies MA; Bor J; Wandeler G; Stinson K; Wood R; Prozesky H; Tanser F; Fatti G; Boulle A; Sikazwe I; Wool-Kaloustian K; Yuannoutsos C; Leroy V; de Rekeneire N; Fox MP
    AIDS; 2017 Jan; 31(1):147-157. PubMed ID: 27776039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of factors that influence antiretroviral regimen change and the subsequent patient outcomes at a Regional Hospital in rural KwaZulu-Natal.
    Soorju V; Naidoo P
    Afr J Prim Health Care Fam Med; 2016 Oct; 8(1):e1-e6. PubMed ID: 28155312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy Is Not Associated With Adverse Perinatal Outcomes Among HIV-infected East African Women: A Prospective Study.
    Pintye J; Baeten JM; Celum C; Mugo N; Ngure K; Were E; Bukusi EA; John-Stewart G; Heffron RA
    J Infect Dis; 2017 Dec; 216(12):1561-1568. PubMed ID: 29040666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda.
    Jacobs TG; Okemo D; Ssebagereka A; Mwehonge K; Njuguna EM; Burger DM; Colbers A; Suleman F; Mantel-Teeuwisse AK; Ooms GI
    HIV Med; 2024 Jul; 25(7):805-816. PubMed ID: 38499513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
    Milinkovic A; Martinez E; López S; de Lazzari E; Miró O; Vidal S; Blanco JL; Garrabou G; Laguno M; Arnaiz JA; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
    Antivir Ther; 2007; 12(3):407-15. PubMed ID: 17591031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for first line ART modification over the years during the ART scale up in Uganda.
    Castelnuovo B; Mubiru F; Kalule I; Kiragga A
    AIDS Res Ther; 2019 Oct; 16(1):31. PubMed ID: 31597561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
    Takou D; Fokam J; Teto G; Santoro MM; Ceccherini-Silberstein F; Nanfack AJ; Sosso SM; Dambaya B; Salpini R; Billong SC; Gori C; Fokunang CN; Cappelli G; Colizzi V; Perno CF; Ndjolo A
    BMC Infect Dis; 2019 Mar; 19(1):246. PubMed ID: 30871487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to standards of quality HIV/AIDS care and antiretroviral therapy in the West Nile Region of Uganda.
    Burua A; Nuwaha F; Waiswa P
    BMC Health Serv Res; 2014 Nov; 14():521. PubMed ID: 25399661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.